SENS
Senseonics Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.72
−1.82%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 48.5M | 35.3M | 22.5M | 22.4M | 16.4M |
| Cost of Revenue | 21.9M | 19.5M | 21.9M | 19.3M | 13.7M |
| Gross Profit | 26.6M | 15.8M | 533.0K | 3.1M | 2.7M |
| Operating Expenses | |||||
| R&D Expense | 36.8M | 31.6M | 41.1M | 48.8M | 39.7M |
| SG&A Expense | 98.2M | 52.5M | 34.2M | 29.9M | 31.6M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 135.0M | 84.1M | 75.4M | 78.7M | 71.4M |
| Cost and Expenses | 156.9M | 103.6M | 97.3M | 98.0M | 85.0M |
| Operating Income (EBIT) | (108.4M) | (68.3M) | (74.8M) | (75.6M) | (68.6M) |
| Non-Operating | |||||
| Interest Income | 4.3M | 4.2M | 4.5M | 5.4M | 1.8M |
| Interest Expense | 5.2M | 5.0M | 8.4M | 11.1M | 18.7M |
| Net Interest Income | (845.0K) | (753.0K) | (3.9M) | (5.7M) | (16.9M) |
| Other Non-Op Income/Expense | (1.0M) | (776.0K) | (3.8M) | 15.2M | 210.7M |
| Non-Operating Income (excl Interest) | (4.1M) | (4.2M) | (4.7M) | (26.3M) | (229.4M) |
| EBT (Pre-Tax Income) | (109.4M) | (69.1M) | (78.6M) | (60.4M) | 142.1M |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (109.4M) | (69.1M) | (78.6M) | (60.4M) | 142.1M |
| Earnings from Cont. Ops | (109.4M) | (69.1M) | (78.6M) | (60.4M) | 142.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (109.4M) | (69.1M) | (78.6M) | (60.4M) | (67.2M) |
| Per Share | |||||
| Basic EPS | ($2.27) | ($1.66) | ($2.50) | ($2.20) | $6.07 |
| Diluted EPS | ($2.27) | ($1.66) | ($2.50) | ($2.20) | ($2.17) |
| Revenue Per Share | $0.84 | $0.84 | $0.71 | $0.79 | $0.70 |
| Shares | |||||
| Basic Shares Outstanding | 57.8M | 41.7M | 31.5M | 28.4M | 23.4M |
| Diluted Shares Outstanding | 57.8M | 41.7M | 31.5M | 28.4M | 30.9M |
| Profitability Metrics | |||||
| EBITDA | (102.4M) | (62.6M) | (68.7M) | (48.0M) | 161.8M |
| D&A | 1.9M | 1.5M | 1.5M | 1.3M | 985.0K |
| EBIT | (104.2M) | (64.2M) | (70.2M) | (49.3M) | 160.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026